Levodopa+carbidopa+entacapone Mylan (Entacapone, Levodopa, Carbidopa Monohydrate)

Levodopa is converted to dopamine in the brain, restoring deficient neurotransmission. Carbidopa blocks peripheral conversion of levodopa, increasing its availability to the central nervous system. Entacapone inhibits the COMT enzyme, slowing levodopa breakdown and extending its plasma half‑life, which together provide smoother dopaminergic stimulation.

The dosage regimen is individualized and set by the prescribing clinician based on disease severity, response, and tolerability. Typical treatment involves multiple tablets taken several times daily, but exact strength, frequency, and timing are determined by the healthcare professional.

Safety data in pregnancy and lactation are limited. The product should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Generally, it is avoided during pregnancy and breastfeeding unless specifically advised by a physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Standard levodopa/carbidopa provides dopamine replacement but has a relatively short plasma half‑life, leading to motor fluctuations. Adding entacapone inhibits COMT, prolonging levodopa exposure, reducing OFF time, and often allowing a lower total levodopa dose. This can improve symptom control and may lessen dyskinesia in some patients.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the package is tightly closed to maintain product integrity throughout its shelf life.

The medication is taken orally, usually with food or a light snack to reduce gastrointestinal irritation. Tablets should be swallowed whole with a full glass of water and not crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious adverse events include severe liver injury, neuroleptic malignant syndrome, anaphylactic reactions, marked depression or suicidal thoughts, and rare hematologic abnormalities such as neutropenia. Patients should seek immediate medical attention if they experience symptoms like jaundice, high fever, severe rash, mood changes, or unexplained bleeding.

The product is contraindicated in individuals with known hypersensitivity to any component, those currently taking non‑selective MAO inhibitors, patients with severe hepatic impairment, and individuals with a history of neuroleptic malignant syndrome. Caution is also advised for patients with significant cardiovascular disease or uncontrolled psychiatric disorders.